QA: Neurotrope Inc in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001513856_2012_Neurotrope_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
warning Ignoring company because Liabilities is zero pre-agg {'balance_sheet': {'company_id': '0001513856', 'EntityCommonStockSharesOutstanding': 10200000, 'Assets': 5745, 'AssetsCurrent': 5745, 'CostOfGoodsAndServicesSold': 0, 'Expenses': -11655, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 0, 'LiabilitiesAndStockholdersEquity': 5745, 'LiabilitiesCurrent': 0, 'LiabilitiesNoncurrent': 0, 'NetIncome': -11655, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': -8444, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': -3211, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 5745, 'remainder_NetIncome': 0, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}

Graph

Absolute values for 0001513856, Neurotrope Inc

  xvar xval
0 AssetsCurrent 8,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 0
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 3,600
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 100
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 3,500
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 8,000
1 Liabilities 3,600
2 Expenses 3,600
3 Revenues 0
4 StockholdersEquity 4,400
5 NetIncome -3,600
6 ComprehensiveNetIncome -3,600
7 BaseVar 7,600
8 EconomicCapitalRatiobeforeLimitedLiability 1.03
9 EconomicCapitalRatio 2.33

Edgar->Model Mapping

Feature Distribution